Journals / Meandros Medical And Dental Journal / 2020 / Cilt: 21 - Sayı: 2

Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers

Baş Boyun Kanserlerinde, N0 Boyuna Yaklaşımda Fikir Ayrılıkları ve Nedenleri

Pages
98–103
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In patients with N0 neck, it is required to decide on the most effective prophylactic treatment with low morbidity that can avoid cervical recurrence and distant metastasis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:There are numerous controversial issues in the management of patients with N0 neck.
📊
Key Findings & Data:Whether the diagnosis of N0 neck should be made based on the physical examination or imaging methods is contradictory in the first place.
💡
Conclusion & Impact:In patients with N0 neck, it is required to decide on the most effective prophylactic treatment with low morbidity that can avoid cervical recurrence and distant metastasis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

There are numerous controversial issues in the management of patients with N0 neck. Whether the diagnosis of N0 neck should be made based on the physical examination or imaging methods is contradictory in the first place. The rates of metastasis to the neck and the identification of occult neck metastasis vary according to the location and histopathological characteristics of the primary tumour. A wait-and-see approach may be preferred in the treatment of these patients, whereas an elective neck dissection or elective radiotherapy may be implemented considering all these features. An elective treatment is preferred if the occult metastasis ratio is higher than 15-20%. The neck dissection levels change depending on the primary tumour localisation. In patients with N0 neck, it is required to decide on the most effective prophylactic treatment with low morbidity that can avoid cervical recurrence and distant metastasis.

Özet

Baş boyun kanserlerinde, N0 boyunlu hastalara yaklaşımda birçok tartışmalı konubulunmaktadır. Başta N0 tanısının, muayeneye göre mi, görüntüleme yöntemlerinegöre mi konulacağı tartışmalıdır. Primer tümörün yerleşim yerine ve histopatolojiközelliklerine göre boyuna metastaz yapma ve boyunda okült metastaz saptanmaoranları değişmektedir. Tüm bu özellikler gözetilerek, bu hastaların tedavisinde,bekle-gör şeklinde bir yaklaşım olabildiği gibi, elektif boyun diseksiyonu veyaelektif radyoterapi de uygulanabilmektedir. Boyunda gizli metastaz olasılığı %15- 20’nin üzerinde ise elektif tedavi önerilmektedir. Elektif boyun diseksiyonlarındaprimer tümöre göre diseke edilecek lenf nodu bölgeleri değişmektedir. N0 olanhastalarda, boyun nüksü ve uzak metastazdan koruyan en etkin ve morbiditesidüşük profilaktik tedaviye karar vermek gerekmektedir

🔖

Cite This Article

ERYILMAZ, A., BAŞAL, Y. (2022). Disagreements in the Approach to theN0 Neck and their Causes in Head andNeck Cancers. Meandros Medical And Dental Journal, Cilt: 21 - Sayı: 2, 98–103. https://ajindex.com/articles/579015

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (12)

  1. Pillsbury HC, Clark M. A rationale for therapy of the N0 neck. Laryngoscope 1997; 107: 1294-315. 2. de Bree R, Takes RP, Castelijns JA, Medina JE, Stoeckli SJ, Mancuso AA, et al. Advances in diagnostic modalities to detect occult lymph node metastases in head and neck squamous cell carcinoma. Head Neck 2015; 37: 1829-39
  2. Flach GB, Tenhagen M, de Bree R, Brakenhoff RH, van der Waal I, Bloemena E, et al. Outcome of patients with early stage oral cancer managed by an observation strategy towards the N0 neck using ultrasound guided fine needle aspiration cytology: No survival difference as compared to elective neck dissection. Oral Oncol 2013; 49: 157-64
  3. Nguyen A, Luginbuhl A, Cognetti D, Abel KV, Bar-Ad V, Intenzo C, et al. Effectiveness of PET/CT in the preoperative evaluation of neck disease. Laryngoscope 2014; 124: 159-64
  4. Levent Erişen. Baş Boyun Kanserleri. Baş Boyun Kanserlerinde Boyuna Yaklaşım. 2003 Nobel; 439-502
  5. Fasunla AJ, Greene BH, Timmesfeld N, Wiegand S, Werner JA, Sesterhenn AM. A meta-analysis of the randomized controlled trials on elective neck dissection versus therapeutic neck dissection in oral cavity cancers with clinically node-negative neck. Oral Oncol 2011; 47: 320-4
  6. Huang SF, Chang JT, Liao CT, Jan Kang C, Lin CY, Fan KH, et al. The role of elective neck dissection in early stage buccal cancer. Laryngoscope 2015; 125: 128-33
  7. Chow JM, Levin BC, Krivit JS, Applebaum EL. Radiotherapy or surgery for subclinical cervical node metastases. Arch Otolaryngol Head Neck Surg 1989; 115: 981-4
  8. Al-Rajhi N, Khafaga Y, El-Husseiny J, Saleem M, Mourad W, Al-Otieschan A, et al. Early stage carcinoma of oral tongue: prognostic factors for local control and survival. Oral Oncol 2000; 36: 508-14
  9. Ebrahimi A, Ashford BG, Clark JR. Improved survival with elective neck dissection in thick early-stage oral squamous cell carcinoma. Head Neck 2012; 34: 709-16
  10. Po Wing Yuen A, Lam KY, Lam LK, Ho CM, Chow TL, Yuen WF, et al. Prognostic factors of clinically stage I and II oral tongue carcinoma-A comparative study of stage, thickness, shape, growth pattern, invasive front malignancy grading, MartinezGimeno score, and pathologic features. Head Neck 2002; 24: 513-20
  11. Koss SL, Russell MD, Leem TH, Schiff BA, Smith RV. Occult nodal disease in patients with failed laryngeal preservation undergoing surgical salvage. Laryngoscope 2014; 124: 421-8
  12. Ma H, Lian M, Feng L, Li P, Hou L, Liu H, et al. Management of cervical lymph